Emanuele Forcesi
Impact in
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
-
- Drug-Induced Adverse Reactions
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 2
- Co-authors
- Elisabetta Poluzzi (11 shared papers)Emanuel Raschi (11 shared papers)Fabrizio De Ponti (9 shared papers)Ippazio Cosimo Antonazzo (7 shared papers)Riccardo Mei (1 shared paper)Igor Diemberger (1 shared paper)Giulio Marchesini (3 shared papers)Marco Tuccori (1 shared paper)
In The Last Decade
Emanuele Forcesi
12 papers receiving 315 citations
Peers
Comparison fields: 5 of 56
- Toxicology 36
- Pharmacology 26
- Infectious Diseases 49
- Cardiology and Cardiovascular Medicine 55
- Oncology 54
Countries citing papers authored by Emanuele Forcesi
This map shows the geographic impact of Emanuele Forcesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuele Forcesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuele Forcesi more than expected).
Fields of papers citing papers by Emanuele Forcesi
This network shows the impact of papers produced by Emanuele Forcesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuele Forcesi. The network helps show where Emanuele Forcesi may publish in the future.
Co-authors
The 25 scholars most cited alongside Emanuele Forcesi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 85 | |
| 2 | 2018 | 68 | |
| 3 | 2017 | 38 | |
| 4 | 2018 | 27 | |
| 5 | 2018 | 26 | |
| 6 | 2019 | 25 | |
| 7 | 2020 | 19 | |
| 8 | 2018 | 11 | |
| 9 | 2018 | 8 | |
| 10 | 2018 | 7 | |
| 11 | 2019 | 3 | |
| 12 | 2019 | 3 | |
| 13 | Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study | 2020 | 0 |
About Emanuele Forcesi
Emanuele Forcesi is a scholar working on Toxicology, Pharmacology, Cardiology and Cardiovascular Medicine, Biotechnology and Hematology, having authored 13 papers that have together received 320 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (2 papers), Multiple Sclerosis Research Studies (1 paper), Autoimmune and Inflammatory Disorders Research (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Atrial Fibrillation Management and Outcomes (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper), Microbial Metabolism and Applications (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Toxicology (36 citations), Pharmacology (26 citations), Infectious Diseases (49 citations), Cardiology and Cardiovascular Medicine (55 citations) and Oncology (54 citations). Emanuele Forcesi has collaborated with scholars based in Italy, France and Norway. Frequent co-authors include Elisabetta Poluzzi, Emanuel Raschi, Fabrizio De Ponti, Ippazio Cosimo Antonazzo, Riccardo Mei, Igor Diemberger, Giulio Marchesini, Marco Tuccori, Ugo Moretti and M. La Plaça. Their work appears in journals such as Acta Diabetologica, Multiple Sclerosis Journal, Cardiovascular Drugs and Therapy, Drug Safety and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.